Prelude Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Prelude Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-116,316	Closed	-$1.91M	–	1587
2023 Q4	$1.91M	Buy	+116,316	New	+$1.83M	0.13%	176

Prelude Capital Management's ORTX Position: Q1 2024 in Review

Prelude Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 116,316 shares — an estimated $1.91M sold.

Prelude Capital Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.91M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Prelude Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Prelude Capital Management sold 116,316 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $1.91M.
Prelude Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Prelude Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.91M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.